Campbell Murray

Company: Agent Capital

Job title: Partner

Seminars:

Panel Discussion: Evaluating Investor Interest in Next-Generation Gene Therapy Technologies 5:00 pm

What innovation in gene therapy vector development makes for an attractive investment proposition? What differentiating factors and data packages are big pharma looking for to acquire or collaborate with new startups? Looking beyond rare disease: are investors confident that better delivery tools could enable gene therapy success in more prevalent conditions?Read more

day: Conference Day One